Vc-MMAE

AP>99%

Palbociclib (monohydrochloride) is a highly selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6), which play a crucial role in regulating cell cycle progression. By inhibiting CDK4/6, Palbociclib effectively arrests cell cycle progression, particularly in cancer cells that rely on CDK4/6 activi...

特格拉赞  AP≥99.O%

AP>99%

4-(6-Aminopyridin-3-yl)piperazine-1-carboxylic acid tert-butyl ester is a pharmaceutical intermediate, primarily used for the synthesis of the active pharmaceutical ingredient Palbociclib.

Trabectedin （Yondelis） 是一种烷化剂，用于治疗既往接受过含蒽环类药物方案的不可切除或转移性脂肪肉瘤或平滑肌肉瘤患者。

AP>99%  阿维巴坦中间体

(R,E)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid is an organic compound containing a tert-butoxycarbonyl (Boc) protecting group, primarily used as a pharmaceutical intermediate. This compound introduces a tert-butoxycarbonyl group to the amino group to protect it, ens...

2-(((3aR,4S,6R,6aS)-6-((5-Amino-6-chloro-2-(propylthio)pyrimidin-4-yl)amino)-2,2-dimethyltetrahydro-3aH-cyclopenta[d][1,3]dioxol-4-yl)oxy)ethanol is a complex organic compound with a polycyclic structure and multiple functional groups. Its molecular structure contains amino, chloro, propylthio, and tetrahy...

2-[[(3aR,4S,6R,6aS)-6-Amino-tetrahydro-2,2-dimethyl-4H-cyclopenta[1,3]dioxin-4-yl]oxy]-ethanol (2R,3R)-2,3-dihydroxybutanedioate is an intermediate used in laboratory organic synthesis and pharmaceutical research and development. It is an intermediate for the active pharmaceutical ingredient Tegaserod.

The melting point of 2-chloro-8-cyclopentyl-5-methyl-8H-pyrido[2,3-d]pyrimidin-7-one is between 176°C and 178°C, with a density of 1.3. Under normal temperature and pressure, it appears as a yellow or dark yellow solid. Its solubility in chloroform and methanol is moderate, but it dissolves better when hea...

2,3,4,5-Tetrahydro-7,8-dinitro-3-(trifluoroacetyl)-1,5-methano-1H-3-benzazepine is a complex organic compound and a derivative of benzazepine.

ChemExpress have been shortlisted for Best CRO (Contract Research Organization) at the 11th World ADC Awards. 

Founded in 2006, ChemExpress focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. Our comprehensive CRO & CDMO platform is engaged in the research and development, manufacturing and supply of regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs and drug products. We are a one-stop service platform to support our client’s projects from early drug discovery, process development to commercialization.

ChemExpress have received EIR with the conclusion of the inspection, no FDA 483, Observations, was issued by US FDA on August 8th.

ChemExpress CDMO Services brochure (CDMO）

ChemExpress focuses on providing small molecule and new modalities CDMO services for both pharmaceutical and biotech clients. 

ChemExpress ADC Products handbook (ADC)

ChemExpress FTE & FFS Services Flyer (FTE&FFS)

DMF Filed ADC Small Molecule Products